COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Tissue Sample Study for Mitochondrial Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01803906
Recruitment Status : Suspended (Recruitment on hold)
First Posted : March 4, 2013
Last Update Posted : April 20, 2020
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Columbia University

Brief Summary:
The investigators are studying patients with undefined mitochondrial diseases to identify genetic mutations in nuclear or mitochondrial Deoxyribonucleic Acid (DNA). Most patients with suspected or known mitochondrial diseases have no genetic confirmation. The investigators expect that evaluating tissue samples from patients with mitochondrial disorders will lead us to discover mutations in new or known genes causing mitochondrial dysfunction.

Condition or disease
Mitochondrial Disorders Mitochondrial Disease Melas Kearns Sayer NARP MNGIE LHON Mitochondrial Depletion Syndrome Leigh's Disease

Detailed Description:

Presently, the investigators know of about 200 mitochondrial disorders. The investigators know that there are about 1,300 genes responsible for mitochondrial function. Thus, there are a lot of mutated genes to be discovered out there. Currently, most patients with suspected or known mitochondrial disorders do not have genetic confirmation of the disease.

The goal of this project is to perform biochemical and DNA analysis on tissue samples of patients with mitochondrial disorders to find new genes that might be involved in mitochondrial dysfunction.

Leftover patient tissue samples will be obtained for analysis from within the Columbia Presbyterian Medical Center. Left over patient samples may also be sent from outside the institution. This is not a "first-step" in the diagnostic process, but rather an option for evaluation in patient samples for which no known diagnosis or genetic confirmation has been made.

The research laboratory does not guarantee that a sample will be analyzed. Sample analysis is performed according to research interest. If they choose, patients can be contacted should laboratory findings provide insight into their disease.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 6900 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Tissue Study for Mitochondrial Disorders
Study Start Date : February 2012
Estimated Primary Completion Date : January 2021
Estimated Study Completion Date : January 2021

Mitochondrial disease
Patients with known or suspected DNA mutations that affect mitochondrial function. Patients with suspected mitochondrial disorders

Primary Outcome Measures :
  1. Number of patients with reduced respiratory chain enzyme levels [ Time Frame: Up to 2 years ]
    Biochemical studies involving mitochondrial function. The levels will be compared to normal levels.

Secondary Outcome Measures :
  1. Number of new genetic mutations [ Time Frame: Up to 2 years ]
    Evaluation of potential genetic interaction in clinical signs and symptoms.

Biospecimen Retention:   Samples With DNA
Any type of tissue could be submitted, however, generally blood, urine, buccal cell (cheek), and muscle are sent.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients of all ages, race, gender with known or suspected mitochondrial disorders and their carrier relatives (if requested).

Inclusion Criteria:

  • Patients suspected of having a mitochondrial disorder
  • Patients who may carry a genetic mutation or be related to someone with a genetic mutation which may cause a mitochondrial disorder

Exclusion Criteria:

  • Patients who are not suspected of having a mitochondrial disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01803906

Layout table for location information
United States, New York
Columbia University
New York, New York, United States, 10032
Sponsors and Collaborators
Columbia University
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Layout table for investigator information
Principal Investigator: Salvatore DiMauro, MD Columbia University
Additional Information:
Layout table for additonal information
Responsible Party: Columbia University Identifier: NCT01803906    
Other Study ID Numbers: AAAB5754
P01HD032062 ( U.S. NIH Grant/Contract )
First Posted: March 4, 2013    Key Record Dates
Last Update Posted: April 20, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: When applicable we will submit manuscript (s) describing the findings
Keywords provided by Columbia University:
mitochondrial disorder
oxidative phosphorylation
oxidative phosphorylation disorders
respiratory chain disorders
mitochondrial disease
kearns sayer
Mitochondrial depletion syndrome
Leigh's disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Leigh Disease
Mitochondrial Diseases
Pathologic Processes
Metabolic Diseases
Brain Diseases, Metabolic, Inborn
Brain Diseases, Metabolic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Metabolism, Inborn Errors
Genetic Diseases, Inborn
Pyruvate Metabolism, Inborn Errors
Carbohydrate Metabolism, Inborn Errors